Acadia Pharmaceuticals | ACAD - 市值

股票价格

21.96

每天变化

-0.15 -0.68%

每月一次

-0.23%

每年

49.08%

Q2 预测

21.49

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.63B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	市值	更改		日
Acadia Pharmaceuticals	USD 4.52B		919M	2025-12
ALKERMES	USD 4.62B		333M	2025-12
Alnylam Pharmaceuticals	USD 52.54B		7.24B	2025-12
Biogen	USD 25.82B		5.28B	2025-12
BioMarin Pharmaceutical	USD 11.42B		1.02B	2025-12
Bristol-Myers Squibb	USD 109.81B		18.01B	2025-12
Cara Therapeutics	USD 366M		338M	2025-09
Corcept Therapeutics	USD 3.66B		5.1B	2025-12
Cytokinetics	USD 7.77B		1.19B	2025-12
Eisai	JPY 1.31T		140.95B	2025-12
Eli Lilly	USD 1.02T		293.84B	2025-12
Incyte	USD 19.39B		2.83B	2025-12
J&J	USD 561.65B		17.5B	2026-04
Neurocrine Biosciences	USD 14.14B		218M	2025-12
Pfizer	USD 141.57B		6.48B	2025-12
Prothena	USD 514M		11M	2025-12
PTC Therapeutics	USD 5.26B		844M	2026-04
Sarepta Therapeutics	USD 2.26B		238M	2025-12
Ultragenyx Pharmaceutical	USD 2.22B		680M	2025-12
Vanda Pharmaceuticals	USD 279M		6M	2024-12
Vertex Pharmaceuticals	USD 115.03B		14.61B	2025-12